Clinical Trial Update: Study of Specific Allergen Immunotherapy in Grass Pollen Allergic Subjects by Epicutaneous Allergen Administration [Phase 2]

View source ↗

Summary

A Phase 2 study evaluating epicutaneous immunotherapy for grass pollen allergy has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Seasonal Allergic Rhinitis

Snippet

Sponsor: University of Zurich | Conditions: Allergies | Phase 2 | Status: COMPLETED